The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
    1. About this group
    2. Reviews
      1. Active placebos versus antidepressants for depressionReview
      2. Acupuncture for depressionReview
      3. Acupuncture for insomniaReview
      4. Agomelatine versus other antidepressive agents for major depressionReview
      5. Alprazolam for depressionReview
      6. Alternating current cranial electrotherapy stimulation (CES) for depressionReview
      7. Amitriptyline for depressionReview
      8. Amitriptyline versus placebo for major depressive disorderReview
      9. Antidepressant prevention of postnatal depressionReview
      10. Antidepressant treatment for postnatal depressionReview
      11. Antidepressants for anorexia nervosaReview
      12. Antidepressants for depressed elderlyReview
      13. Antidepressants for depression in medical illnessReviewWithdrawn
      14. Antidepressants for depression in physically ill peopleReview
      15. Antidepressants for generalized anxiety disorderReview
      16. Antidepressants plus benzodiazepines for major depressionReview
      17. Antidepressants versus placebo for depression in primary careReview
      18. Antidepressants versus placebo for people with bulimia nervosaReview
      19. Antidepressants versus placebo for the depressed elderlyReview
      20. Antidepressants versus psychological treatments and their combination for bulimia nervosaReview
      21. Antiglucocorticoid treatments for mood disordersReview
      22. Aripiprazole alone or in combination for acute maniaReview
      23. Azapirones for generalized anxiety disorderReview
      24. Azapirones versus placebo for panic disorder in adultsReview
      25. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescentsReview
      26. Behavioural therapies versus other psychological therapies for depressionReview
      27. Citalopram versus other anti-depressive agents for depressionReview
      28. Cognitive behaviour therapy for chronic fatigue syndrome in adultsReview
      29. Cognitive behavioural therapy for anxiety disorders in children and adolescentsReview
      30. Collaborative care for depression and anxiety problemsReview
      31. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)Review
      32. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobiaReview
      33. Combined psychotherapy plus benzodiazepines for panic disorderReview
      34. Consultation letters for medically unexplained physical symptoms in primary careReview
      35. Continuation and maintenance treatments for depression in older peopleReview
      36. Counselling for mental health and psychosocial problems in primary careReview
      37. Drugs versus placebo for dysthymiaReview
      38. Duloxetine versus other anti-depressive agents for depressionReview
      39. Early psychological interventions to treat acute traumatic stress symptomsReview
      40. Electroconvulsive therapy for the depressed elderlyReview
      41. Enhanced care by generalists for functional somatic symptoms and disorders in primary careReview
      42. Escitalopram versus other antidepressive agents for depressionReview
      43. Exercise for depressionReview
      44. Exercise in prevention and treatment of anxiety and depression among children and young peopleReview
      45. Exercise therapy for chronic fatigue syndromeReview
      46. Family interventions for bipolar disorderReview
      47. Family therapy for anorexia nervosaReview
      48. Family therapy for depressionReview
      49. Fluoxetine versus other types of pharmacotherapy for depressionReview
      50. Fluvoxamine versus other anti-depressive agents for depressionReview
      51. Folate for depressive disordersReview
      52. Haloperidol alone or in combination for acute maniaReview
      53. Hydroxyzine for generalised anxiety disorderReview
      54. Individual psychotherapy in the outpatient treatment of adults with anorexia nervosaReview
      55. Inositol for depressive disordersReview
      56. Interventions for helping people recognise early signs of recurrence in bipolar disorderReview
      57. Interventions for pathological gamblingReviewWithdrawn
      58. Interventions for preventing eating disorders in children and adolescentsReview
      59. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescentsReview
      60. Interventions for vaginismusReview
      61. Interventions to facilitate return to work in adults with adjustment disordersReview
      62. Kava extract versus placebo for treating anxietyReview
      63. Light therapy for non-seasonal depressionReview
      64. Lithium for maintenance treatment of mood disordersReview
      65. Lithium versus antidepressants in the long-term treatment of unipolar affective disorderReview
      66. Low dosage tricyclic antidepressants for depressionReview
      67. Marital therapy for depressionReview
      68. Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adultsReview
      69. Meditation therapy for anxiety disordersReview
      70. Melatonin for the prevention and treatment of jet lagReview
      71. Milnacipran versus other antidepressive agents for depressionReview
      72. Mirtazapine versus other antidepressive agents for depressionReview
      73. Multiple session early psychological interventions for the prevention of post-traumatic stress disorderReview
      74. Music therapy for depressionReview
      75. Newer generation antidepressants for depressive disorders in children and adolescentsReview
      76. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adultsReview
      77. Olanzapine alone or in combination for acute maniaReview
      78. Olanzapine in long-term treatment for bipolar disorderReview
      79. Omega-3 fatty acids for bipolar disorderReview
      80. Oxcarbazepine for acute affective episodes in bipolar disorderReview
      81. Oxcarbazepine in the maintenance treatment of bipolar disorderReview
      82. Paraprofessionals for anxiety and depressive disordersReview
      83. Paroxetine versus other anti-depressive agents for depressionReview
      84. Passiflora for anxiety disorderReview
      85. Pharmacological interventions for preventing post-traumatic stress disorder (PTSD)Review
      86. Pharmacological interventions for somatoform disorders in adultsReviewNew
      87. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary diseaseReview
      88. Pharmacological treatment for psychotic depressionReview
      89. Pharmacotherapy and psychotherapy for body dysmorphic disorderReview
      90. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disordersReview
      91. Pharmacotherapy for anxiety disorders in children and adolescentsReview
      92. Pharmacotherapy for dysthymiaReview
      93. Pharmacotherapy for post traumatic stress disorder (PTSD)Review
      94. Pharmacotherapy for social anxiety disorderReview
      95. Pharmacotherapy for trichotillomaniaReview
      96. Psychological and educational interventions for preventing depression in children and adolescentsReview
      97. Psychological debriefing for preventing post traumatic stress disorder (PTSD)Review
      98. Psychological, social and welfare interventions for psychological health and well-being of torture survivorsReview
      99. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adultsReview
      100. Psychological therapies for generalised anxiety disorderReview
      101. Psychological therapies for pathological and problem gamblingReview
      102. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescentsReview
      103. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsReview
      104. Psychological treatments for bulimia nervosa and bingingReview
      105. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD)Review
      106. Psychosocial and pharmacological treatments for deliberate self harmReview
      107. Psychosocial and psychological interventions for treating postpartum depressionReview
      108. Psychosocial interventions by general practitionersReview
      109. Psychosocial interventions for conversion disorderReview
      110. Psychosocial interventions for prevention of psychological disorders in law enforcement officersReview
      111. Psychostimulants for depressionReview
      112. Psychotherapeutic treatments for older depressed peopleReview
      113. Psychotherapies for hypochondriasisReview
      114. Relaxation for depressionReview
      115. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adultsReview
      116. Risperidone alone or in combination for acute maniaReview
      117. Risperidone in long-term treatment for bipolar disorderReview
      118. Screening and case finding instruments for depressionReview
      119. Second-generation antidepressants for seasonal affective disorderReview
      120. Second-generation antipsychotics for anxiety disordersReview
      121. Second-generation antipsychotics for major depressive disorder and dysthymiaReview
      122. Second-generation antipsychotics for obsessive compulsive disorderReview
      123. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)Review
      124. Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depressionReviewWithdrawn
      125. Self-help and guided self-help for eating disordersReview
      126. Sertraline versus other antidepressive agents for depressionReview
      127. Short-term psychodynamic psychotherapies for common mental disordersReview
      128. Sports and games for post-traumatic stress disorder (PTSD)Review
      129. St John's wort for major depressionReview
      130. Strategies for managing sexual dysfunction induced by antidepressant medicationReview
      131. Therapeutic touch for anxiety disordersReview
      132. 'Third wave' cognitive and behavioural therapies versus other psychological therapies for depressionReview
      133. 'Third wave' cognitive and behavioural therapies versus treatment as usual for depressionReview
      134. Tiagabine for acute affective episodes in bipolar disorderReview
      135. Tiagabine in the maintenance treatment of bipolar disorderReview
      136. Topiramate for acute affective episodes in bipolar disorderReview
      137. Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndromeReview
      138. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorderReview
      139. Transcranial magnetic stimulation for treating depressionReview
      140. Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)ReviewWithdrawn
      141. Tricyclic drugs for depression in children and adolescentsReview
      142. Tryptophan and 5-Hydroxytryptophan for depressionReview
      143. Valerian for anxiety disordersReview
      144. Valproate for acute mood episodes in bipolar disorderReview
      145. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorderReview
    3. Protocols
      1. Adjunctive antioxidants for bipolar disorderProtocol
      2. Antidepressants for depression during pregnancyProtocol
      3. Antidepressants for insomniaProtocol
      4. Antidepressants versus placebo for panic disorder in adultsProtocol
      5. Antipsychotic drugs for anorexia nervosaProtocol
      6. Augmentation of psychotherapy with d-cycloserine for anxiety disordersProtocol
      7. Behavioural therapies versus treatment as usual for depressionProtocol
      8. Benzodiazepines and related drugs for older depressed peopleProtocol
      9. Benzodiazepines for generalised anxiety disorder (GAD)Protocol
      10. Benzodiazepines versus placebo for panic disorder in adultsProtocol
      11. Bibliotherapy for sexual dysfunctionProtocol
      12. Bupropion versus other antidepressive agents for depressionProtocol
      13. Cognitive behavioural therapies versus other psychological therapies for depressionProtocol
      14. Cognitive behavioural therapies versus treatment as usual for depressionProtocol
      15. Cognitive behavioural therapy for anxiety disorders in later lifeProtocol
      16. Cognitive behavioural therapy for insomniaProtocolWithdrawn
      17. Couple and family therapies for post-traumatic stress disorder (PTSD)Protocol
      18. Dance movement therapy for depressionProtocol
      19. Debriefing for the prevention of psychological trauma in women following childbirthProtocol
      20. Electroconvulsive therapy for depressionProtocol
      21. Eszopiclone for insomniaProtocol
      22. Exercise therapy for chronic fatigue syndrome (individual patient data)Protocol
      23. Humanistic therapies versus other psychological therapies for depressionProtocol
      24. Humanistic therapies versus treatment as usual for depressionProtocol
      25. Inpatient versus outpatient care, partial hospitalisation and wait-list for people with eating disordersProtocol
      26. Interpersonal, cognitive analytic and other integrative therapies versus other psychological therapies for depressionProtocol
      27. Interpersonal, cognitive analytic and other integrative therapies versus treatment as usual for depressionProtocol
      28. Interventions for helping people recognise early signs of recurrence in depressionProtocol
      29. Interventions for mood and anxiety disorders, and self harm in young offendersProtocol
      30. Light therapy for preventing seasonal affective disorderProtocol
      31. Melatonin and agomelatine for preventing seasonal affective disorderProtocol
      32. Morita therapy for anxiety disordersProtocol
      33. Newer anticonvulsants in the treatment of anxiety disordersProtocol
      34. Omega-3 fatty acids for depression in adultsProtocol
      35. Pharmacological interventions for adjustment disorders in adultsProtocol
      36. Pharmacological interventions for the treatment of pathological and problem gamblingProtocol
      37. Pharmacological interventions for treatment-resistant depression in adultsProtocol
      38. Pharmacotherapy for anxiety disorders and comorbid alcohol dependencyProtocol
      39. Pharmacotherapy for bipolar disorder in older peopleProtocol
      40. Prevention of depression in chronically physically ill adultsProtocol
      41. Prevention of suicide and suicidal behaviour in adolescentsProtocol
      42. Psychodynamic therapies versus other psychological therapies for depressionProtocol
      43. Psychodynamic therapies versus treatment as usual for depressionProtocol
      44. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorderProtocol
      45. Psychological therapies for panic disorder with or without agoraphobia in adultsProtocol
      46. Psychological therapies for preventing seasonal affective disorderProtocol
      47. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary diseaseProtocol
      48. Psychological therapies for treatment-resistant depression in adultsProtocol
      49. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adultsProtocol
      50. Psychosocial interventions for prevention of depression in older peopleProtocol
      51. Psychotherapy for depression in children and adolescentsProtocol
      52. Ramelteon for insomniaProtocol
      53. Reboxetine versus other antidepressive agents for depressionProtocol
      54. Reiki treatment for psychological symptomsProtocol
      55. Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adultsProtocol
      56. S-adenosyl methionine (SAM-e) for depression in adultsProtocol
      57. Second-generation antidepressants for preventing seasonal affective disorderProtocol
      58. Self-report screening instruments for post-traumatic stress disorder (PTSD) in survivors of traumatic experiencesProtocolDiagnostic
      59. Therapist-delivered distance cognitive behavioural therapy for anxiety disorders in adultsProtocol
      60. Transcranial magnetic stimulation for post-traumatic stress disorderProtocol
      61. Venlafaxine versus other anti-depressive agents for depressionProtocol
      62. Zaleplon for insomniaProtocol
      63. Zolpidem for insomniaProtocol
      64. Zopiclone for insomniaProtocol
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH